A Modified RMCE-Compatible Rosa26 Locus for the Expression of Transgenes from Exogenous Promoters

• Jan S. Tchorz,

  Affiliations Novartis Institute for Biomedical Research, Developmental and Molecular Pathways, Novartis Pharma AG, Basel, Switzerland, Department of Biomedicine, Institute of Physiology, University of Basel, Basel, Switzerland

  ⨯
• Thomas Suply,

  Affiliation Novartis Institute for Biomedical Research, Developmental and Molecular Pathways, Novartis Pharma AG, Basel, Switzerland

  ⨯
• Iwona Ksiazek,

  Affiliation Novartis Institute for Biomedical Research, Developmental and Molecular Pathways, Novartis Pharma AG, Basel, Switzerland

  ⨯
• Claudio Giachino,

  Affiliation Max-Planck Institute for Immunobiology, Freiburg, Germany

  ⨯
• Dimitri Cloëtta,

  Affiliation Department of Biomedicine, Institute of Physiology, University of Basel, Basel, Switzerland

  ⨯
• Claus-Peter Danzer,

  Affiliation Novartis Institute for Biomedical Research, Developmental and Molecular Pathways, Novartis Pharma AG, Basel, Switzerland

  ⨯
• Thierry Doll,

  Affiliation Novartis Institute for Biomedical Research, Developmental and Molecular Pathways, Novartis Pharma AG, Basel, Switzerland

  ⨯
• Andrea Isken,

  Affiliation Novartis Institute for Biomedical Research, Developmental and Molecular Pathways, Novartis Pharma AG, Basel, Switzerland

  ⨯
• Marianne Lemaistre,

  Affiliation Novartis Institute for Biomedical Research, Developmental and Molecular Pathways, Novartis Pharma AG, Basel, Switzerland

  ⨯
• Verdon Taylor,

  Affiliations Max-Planck Institute for Immunobiology, Freiburg, Germany, Department of Biomedical Science, Centre for Stem Cell Biology, University of Sheffield, Sheffield, United Kingdom

  ⨯
• Bernhard Bettler,

  Affiliation Department of Biomedicine, Institute of Physiology, University of Basel, Basel, Switzerland

  ⨯
• Bernd Kinzel,

  Affiliation Novartis Institute for Biomedical Research, Developmental and Molecular Pathways, Novartis Pharma AG, Basel, Switzerland

  ⨯
• Matthias Mueller

  * E-mail: matthias.mueller@novartis.com

  Affiliation Novartis Institute for Biomedical Research, Developmental and Molecular Pathways, Novartis Pharma AG, Basel, Switzerland

  ⨯